Ten-Protein Blood Panel Identifies ALS with High Accuracy
A 10-protein blood test distinguished people with ALS from healthy controls with 98% balanced accuracy in an Emory University study.
Emory Researchers Identify Ten Proteins Linked to ALS
A panel of 10 blood proteins distinguished people with amyotrophic lateral sclerosis (ALS) from healthy individuals with nearly 98% balanced accuracy in a study from Emory University School of Medicine. The research, published in Nature Communications, analyzed blood samples from 632 patients diagnosed with ALS and 160 healthy individuals.
Currently, no single clinical test exists to confirm an ALS diagnosis. Patients frequently wait nearly a year after muscle symptoms start before receiving a definitive diagnosis from a specialist.
The combination of 10 proteins performed better than neurofilament light chain (NfL) alone. While NfL serves as an established marker of nerve injury, blood levels can also rise during other neurological disorders.
Advanced Testing Technology Detects Low-Abundance Blood Proteins
Researchers measured the protein panel using Nucleic Acid Linked Immuno-Sandwich Assay (NULISA), a testing method designed to quantify extremely low levels of target molecules. Damaged nerve cells shed specific proteins into the circulation in very small quantities.
Because informative disease indicators circulate at much lower concentrations than standard blood proteins, standard assays often miss them. NULISA provided the sensitivity required to measure trace proteins tied to nerve-cell injury and inflammation in the patient samples.
Evaluating multiple biological processes at once gave researchers a more complete assessment than tracking any individual marker.
Earlier Diagnostic Clues Could Reduce Testing Delays
Earlier identification of ALS through a blood screen could help community doctors direct patients to neuromuscular specialists sooner. Early symptoms such as muscle weakness, cramping, and walking difficulties frequently mimic less severe conditions, which stalls clinical referrals.
Shortening the evaluation period gives patients more time to discuss management strategies with their physicians. Earlier confirmation also allows individuals to consider participation in clinical trials and organize long-term care plans before functional losses progress.
Further Studies Must Test Against Lookalike Neurological Disorders
The primary limitation of the study is that researchers evaluated the 10-protein panel only against healthy control participants. The trial did not test whether the panel can tell ALS apart from other neurological and neuromuscular conditions that produce similar early symptoms.
Additional prospective studies are required before this protein panel can serve as a routine diagnostic tool in general clinical practice. Anyone experiencing persistent muscle twitching, progressive weakness, or walking problems should consult a neurologist for comprehensive evaluation.
- The panel requires validation against other neuromuscular diseases, not just healthy controls.
- The current study represents observational biomarker discovery, not an approved diagnostic test.
Related Articles
Smart Floss Prototype Measures Blood Sugar and Gum Inflammation
A prototype dental floss device developed by HKUST researchers samples gingival fluid to measure...
Read article TestingNight-Shift Work Linked to Differences in Heart Structure and Blood Markers
An observational study of 42,671 adults links frequent night-shift work to thicker heart walls,...
Read article TestingBlood Test for P-Tau217 Estimates Ten-Year Cognitive Impairment Risk
A Mayo Clinic study in JAMA Neurology shows blood p-tau217 combined with age and genetics can...
Read article TestingBiomarker for GHB Detection Extends Forensic Testing Window
A University of Zurich study in Drug Testing and Analysis shows the biomarker GHB-pentose...
Read articleWant these markers actually tested and explained?
Opt Health draws 55+ biomarkers at home or at one of 2,000+ lab locations, then a physician sits down with the results and tells you what they mean for you — not just whether they're inside the reference range.
See what Opt Health tests →Topic updates
Get the weekly lab marker roundup
Blood test interpretation, optimal ranges, fasting insulin, A1C, thyroid panels, testosterone, cortisol, and nutrient markers.
Understand Your Health Better
Our free assessment maps your symptoms to the most relevant guides, tools, and product recommendations.
Take the Free Assessment →Free · Takes 5 minutes · Instant results